APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amides Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amides Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchAmides Anesthetic Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Amides Anesthetic Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Amides Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amides Anesthetic Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Amides Anesthetic Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Amides Anesthetic market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Amides Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amides Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amides Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amides Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amides Anesthetic include Sun Pharmaceutical, Kelun, Rundu Pharma, Johnson & Johnson, Novartis, Mylan, Lifeon, Jumpcan Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amides Anesthetic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amides Anesthetic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amides Anesthetic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amides Anesthetic market size, projected growth trends, production technologies, key applications, and end-use industries.

Amides Anesthetic Segment by Company

Sun Pharmaceutical

Kelun

Rundu Pharma

Johnson & Johnson

Novartis

Mylan

Lifeon

Jumpcan Pharmaceutical

Pfizer

Hengrui

B. Braun

AstraZeneca

Zoetis

Pacira

Hospira

Hikma Pharmaceuticals

Endo Pharmaceuticals

Baxter International

Amides Anesthetic Segment by Type

Short-Acting

Long-Acting

Medium-Acting

Amides Anesthetic Segment by Application

Hospital

Clinic

Amides Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amides Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amides Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amides Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amides Anesthetic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amides Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Amides Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Amides Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Amides Anesthetic Industry Trends Table 2. Amides Anesthetic Industry Drivers Table 3. Amides Anesthetic Industry Opportunities and Challenges Table 4. Amides Anesthetic Industry Restraints Table 5. Global Amides Anesthetic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Amides Anesthetic Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Amides Anesthetic Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Amides Anesthetic Sales Market Share by Manufacturers Table 9. Global Amides Anesthetic Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Amides Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Amides Anesthetic Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Amides Anesthetic Manufacturers, Product Type & Application Table 13. Global Amides Anesthetic Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Amides Anesthetic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Short-Acting Table 17. Major Manufacturers of Long-Acting Table 18. Major Manufacturers of Medium-Acting Table 19. Global Amides Anesthetic Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Amides Anesthetic Sales by Type (2021-2026) & (Kg) Table 21. Global Amides Anesthetic Sales by Type (2027-2032) & (Kg) Table 22. Global Amides Anesthetic Sales Market Share by Type (2021-2026) Table 23. Global Amides Anesthetic Sales Market Share by Type (2027-2032) Table 24. Global Amides Anesthetic Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Amides Anesthetic Revenue by Type (2021-2026) & (Kg) Table 26. Global Amides Anesthetic Revenue by Type (2027-2032) & (Kg) Table 27. Global Amides Anesthetic Revenue Market Share by Type (2021-2026) Table 28. Global Amides Anesthetic Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global Amides Anesthetic Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Amides Anesthetic Sales by Application (2021-2026) & (Kg) Table 33. Global Amides Anesthetic Sales by Application (2027-2032) & (Kg) Table 34. Global Amides Anesthetic Sales Market Share by Application (2021-2026) Table 35. Global Amides Anesthetic Sales Market Share by Application (2027-2032) Table 36. Global Amides Anesthetic Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Amides Anesthetic Revenue by Application (2021-2026) & (Kg) Table 38. Global Amides Anesthetic Revenue by Application (2027-2032) & (Kg) Table 39. Global Amides Anesthetic Revenue Market Share by Application (2021-2026) Table 40. Global Amides Anesthetic Revenue Market Share by Application (2027-2032) Table 41. Global Amides Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Amides Anesthetic Sales by Region (2021-2026) & (Kg) Table 43. Global Amides Anesthetic Sales Market Share by Region (2021-2026) Table 44. Global Amides Anesthetic Sales Forecasted by Region (2027-2032) & (Kg) Table 45. Global Amides Anesthetic Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 47. North America Amides Anesthetic Sales by Country (2021-2026) & (Kg) Table 48. North America Amides Anesthetic Sales by Country (2027-2032) & (Kg) Table 49. Europe Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. Europe Amides Anesthetic Sales by Country (2021-2026) & (Kg) Table 51. Europe Amides Anesthetic Sales by Country (2027-2032) & (Kg) Table 52. Asia Pacific Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Asia Pacific Amides Anesthetic Sales by Country (2021-2026) & (Kg) Table 54. Asia Pacific Amides Anesthetic Sales by Country (2027-2032) & (Kg) Table 55. South America, Middle East and Africa Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. South America, Middle East and Africa Amides Anesthetic Sales by Country (2021-2026) & (Kg) Table 57. South America, Middle East and Africa Amides Anesthetic Sales by Country (2027-2032) & (Kg) Table 58. Global Amides Anesthetic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Amides Anesthetic Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Amides Anesthetic Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Amides Anesthetic Revenue Market Share by Region (2021-2026) Table 62. Global Amides Anesthetic Revenue Market Share by Region (2027-2032) Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Amides Anesthetic Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Kelun Company Information Table 69. Kelun Business Overview Table 70. Kelun Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kelun Amides Anesthetic Product Portfolio Table 72. Kelun Recent Development Table 73. Rundu Pharma Company Information Table 74. Rundu Pharma Business Overview Table 75. Rundu Pharma Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Rundu Pharma Amides Anesthetic Product Portfolio Table 77. Rundu Pharma Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Amides Anesthetic Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis Amides Anesthetic Product Portfolio Table 87. Novartis Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan Amides Anesthetic Product Portfolio Table 92. Mylan Recent Development Table 93. Lifeon Company Information Table 94. Lifeon Business Overview Table 95. Lifeon Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lifeon Amides Anesthetic Product Portfolio Table 97. Lifeon Recent Development Table 98. Jumpcan Pharmaceutical Company Information Table 99. Jumpcan Pharmaceutical Business Overview Table 100. Jumpcan Pharmaceutical Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jumpcan Pharmaceutical Amides Anesthetic Product Portfolio Table 102. Jumpcan Pharmaceutical Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Amides Anesthetic Product Portfolio Table 107. Pfizer Recent Development Table 108. Hengrui Company Information Table 109. Hengrui Business Overview Table 110. Hengrui Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hengrui Amides Anesthetic Product Portfolio Table 112. Hengrui Recent Development Table 113. B. Braun Company Information Table 114. B. Braun Business Overview Table 115. B. Braun Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. B. Braun Amides Anesthetic Product Portfolio Table 117. B. Braun Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. AstraZeneca Amides Anesthetic Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Zoetis Company Information Table 124. Zoetis Business Overview Table 125. Zoetis Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Zoetis Amides Anesthetic Product Portfolio Table 127. Zoetis Recent Development Table 128. Pacira Company Information Table 129. Pacira Business Overview Table 130. Pacira Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Pacira Amides Anesthetic Product Portfolio Table 132. Pacira Recent Development Table 133. Hospira Company Information Table 134. Hospira Business Overview Table 135. Hospira Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Hospira Amides Anesthetic Product Portfolio Table 137. Hospira Recent Development Table 138. Hikma Pharmaceuticals Company Information Table 139. Hikma Pharmaceuticals Business Overview Table 140. Hikma Pharmaceuticals Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Hikma Pharmaceuticals Amides Anesthetic Product Portfolio Table 142. Hikma Pharmaceuticals Recent Development Table 143. Endo Pharmaceuticals Company Information Table 144. Endo Pharmaceuticals Business Overview Table 145. Endo Pharmaceuticals Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Endo Pharmaceuticals Amides Anesthetic Product Portfolio Table 147. Endo Pharmaceuticals Recent Development Table 148. Baxter International Company Information Table 149. Baxter International Business Overview Table 150. Baxter International Amides Anesthetic Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Baxter International Amides Anesthetic Product Portfolio Table 152. Baxter International Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Amides Anesthetic Distributors List Table 156. Amides Anesthetic Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Amides Anesthetic Product Image Figure 2. Global Amides Anesthetic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amides Anesthetic Market Size (2021-2032) & (US$ Million) Figure 4. Global Amides Anesthetic Sales (2021-2032) & (Kg) Figure 5. Global Amides Anesthetic Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Amides Anesthetic Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Short-Acting Image Figure 9. Long-Acting Image Figure 10. Medium-Acting Image Figure 11. Global Amides Anesthetic Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Amides Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Amides Anesthetic Sales Market Share by Type (2021-2032) Figure 14. Global Amides Anesthetic Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Amides Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Amides Anesthetic Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Amides Anesthetic Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Amides Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Amides Anesthetic Sales Market Share by Application (2021-2032) Figure 22. Global Amides Anesthetic Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Amides Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Amides Anesthetic Revenue Market Share by Application (2021-2032) Figure 25. North America Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 26. North America Amides Anesthetic Sales Market Share by Country (2021-2032) Figure 27. U.S. Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Canada Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Mexico Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Amides Anesthetic Sales Market Share by Country (2021-2032) Figure 32. Germany Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 33. France Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 34. U.K. Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Italy Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Netherlands Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Amides Anesthetic Sales Market Share by Country (2021-2032) Figure 39. China Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Japan Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 41. South Korea Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 42. Southeast Asia Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 43. India Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 44. Australia Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Amides Anesthetic Sales Market Share by Country (2021-2032) Figure 47. Brazil Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South Africa Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Saudi Arabia Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Turkey Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Argentina Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 52. UAE Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Egypt Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Chile Amides Anesthetic Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Global Amides Anesthetic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Amides Anesthetic Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Amides Anesthetic Revenue (2021-2032) & (US$ Million) Figure 58. North America Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Amides Anesthetic Revenue (2021-2032) & (US$ Million) Figure 60. Europe Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Amides Anesthetic Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Amides Anesthetic Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Amides Anesthetic Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Amides Anesthetic Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Short-Acting
  • Long-Acting
  • Medium-Acting
Applications
  • Hospital
  • Clinic
Companies covered
  • Sun Pharmaceutical
  • Kelun
  • Rundu Pharma
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Lifeon
  • Jumpcan Pharmaceutical
  • Pfizer
  • Hengrui
  • B. Braun
  • AstraZeneca
  • Zoetis
  • Pacira
  • Hospira
  • Hikma Pharmaceuticals
  • Endo Pharmaceuticals
  • Baxter International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amides Anesthetic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amides Anesthetic Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Amides Anesthetic Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Amides Anesthetic Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Amides Anesthetic Market Dynamics
  1. 2.1 Amides Anesthetic Industry Trends
  2. 2.2 Amides Anesthetic Industry Drivers
  3. 2.3 Amides Anesthetic Industry Opportunities and Challenges
  4. 2.4 Amides Anesthetic Industry Restraints
3 Amides Anesthetic Market by Manufacturers
  1. 3.1 Global Amides Anesthetic Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Amides Anesthetic Sales by Manufacturers (2021-2026)
  3. 3.3 Global Amides Anesthetic Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Amides Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amides Anesthetic Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Amides Anesthetic Manufacturers, Product Type & Application
  7. 3.7 Global Amides Anesthetic Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amides Anesthetic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amides Anesthetic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amides Anesthetic Tier 1, Tier 2, and Tier 3
4 Amides Anesthetic Market by Type
  1. 4.1 Amides Anesthetic Type Introduction
  2. 4.1.1 Short-Acting
  3. 4.1.2 Long-Acting
  4. 4.1.3 Medium-Acting
  5. 4.2 Global Amides Anesthetic Sales by Type
  6. 4.2.1 Global Amides Anesthetic Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Amides Anesthetic Sales by Type (2021-2032)
  8. 4.2.3 Global Amides Anesthetic Sales Market Share by Type (2021-2032)
  9. 4.3 Global Amides Anesthetic Revenue by Type
  10. 4.3.1 Global Amides Anesthetic Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Amides Anesthetic Revenue by Type (2021-2032)
  12. 4.3.3 Global Amides Anesthetic Revenue Market Share by Type (2021-2032)
5 Amides Anesthetic Market by Application
  1. 5.1 Amides Anesthetic Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Amides Anesthetic Sales by Application
  5. 5.2.1 Global Amides Anesthetic Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Amides Anesthetic Sales by Application (2021-2032)
  7. 5.2.3 Global Amides Anesthetic Sales Market Share by Application (2021-2032)
  8. 5.3 Global Amides Anesthetic Revenue by Application
  9. 5.3.1 Global Amides Anesthetic Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Amides Anesthetic Revenue by Application (2021-2032)
  11. 5.3.3 Global Amides Anesthetic Revenue Market Share by Application (2021-2032)
6 Global Amides Anesthetic Sales by Region
  1. 6.1 Global Amides Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amides Anesthetic Sales by Region (2021-2032)
  3. 6.2.1 Global Amides Anesthetic Sales by Region (2021-2026)
  4. 6.2.2 Global Amides Anesthetic Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Amides Anesthetic Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Amides Anesthetic Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Amides Anesthetic Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Amides Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Amides Anesthetic Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Amides Anesthetic Revenue by Region
  1. 7.1 Global Amides Anesthetic Revenue by Region
  2. 7.1.1 Global Amides Anesthetic Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Amides Anesthetic Revenue by Region (2021-2026)
  4. 7.1.3 Global Amides Anesthetic Revenue by Region (2027-2032)
  5. 7.1.4 Global Amides Anesthetic Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Amides Anesthetic Revenue (2021-2032)
  8. 7.2.2 North America Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Amides Anesthetic Revenue (2021-2032)
  11. 7.3.2 Europe Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Amides Anesthetic Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Amides Anesthetic Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Amides Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Amides Anesthetic Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Kelun
  8. 8.2.1 Kelun Company Information
  9. 8.2.2 Kelun Business Overview
  10. 8.2.3 Kelun Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kelun Amides Anesthetic Product Portfolio
  12. 8.2.5 Kelun Recent Developments
  13. 8.3 Rundu Pharma
  14. 8.3.1 Rundu Pharma Company Information
  15. 8.3.2 Rundu Pharma Business Overview
  16. 8.3.3 Rundu Pharma Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Rundu Pharma Amides Anesthetic Product Portfolio
  18. 8.3.5 Rundu Pharma Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Amides Anesthetic Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Amides Anesthetic Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Amides Anesthetic Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Lifeon
  38. 8.7.1 Lifeon Company Information
  39. 8.7.2 Lifeon Business Overview
  40. 8.7.3 Lifeon Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lifeon Amides Anesthetic Product Portfolio
  42. 8.7.5 Lifeon Recent Developments
  43. 8.8 Jumpcan Pharmaceutical
  44. 8.8.1 Jumpcan Pharmaceutical Company Information
  45. 8.8.2 Jumpcan Pharmaceutical Business Overview
  46. 8.8.3 Jumpcan Pharmaceutical Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jumpcan Pharmaceutical Amides Anesthetic Product Portfolio
  48. 8.8.5 Jumpcan Pharmaceutical Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Amides Anesthetic Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Hengrui
  56. 8.10.1 Hengrui Company Information
  57. 8.10.2 Hengrui Business Overview
  58. 8.10.3 Hengrui Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hengrui Amides Anesthetic Product Portfolio
  60. 8.10.5 Hengrui Recent Developments
  61. 8.11 B. Braun
  62. 8.11.1 B. Braun Company Information
  63. 8.11.2 B. Braun Business Overview
  64. 8.11.3 B. Braun Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 B. Braun Amides Anesthetic Product Portfolio
  66. 8.11.5 B. Braun Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Amides Anesthetic Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Zoetis
  74. 8.13.1 Zoetis Company Information
  75. 8.13.2 Zoetis Business Overview
  76. 8.13.3 Zoetis Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zoetis Amides Anesthetic Product Portfolio
  78. 8.13.5 Zoetis Recent Developments
  79. 8.14 Pacira
  80. 8.14.1 Pacira Company Information
  81. 8.14.2 Pacira Business Overview
  82. 8.14.3 Pacira Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pacira Amides Anesthetic Product Portfolio
  84. 8.14.5 Pacira Recent Developments
  85. 8.15 Hospira
  86. 8.15.1 Hospira Company Information
  87. 8.15.2 Hospira Business Overview
  88. 8.15.3 Hospira Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hospira Amides Anesthetic Product Portfolio
  90. 8.15.5 Hospira Recent Developments
  91. 8.16 Hikma Pharmaceuticals
  92. 8.16.1 Hikma Pharmaceuticals Company Information
  93. 8.16.2 Hikma Pharmaceuticals Business Overview
  94. 8.16.3 Hikma Pharmaceuticals Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hikma Pharmaceuticals Amides Anesthetic Product Portfolio
  96. 8.16.5 Hikma Pharmaceuticals Recent Developments
  97. 8.17 Endo Pharmaceuticals
  98. 8.17.1 Endo Pharmaceuticals Company Information
  99. 8.17.2 Endo Pharmaceuticals Business Overview
  100. 8.17.3 Endo Pharmaceuticals Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Endo Pharmaceuticals Amides Anesthetic Product Portfolio
  102. 8.17.5 Endo Pharmaceuticals Recent Developments
  103. 8.18 Baxter International
  104. 8.18.1 Baxter International Company Information
  105. 8.18.2 Baxter International Business Overview
  106. 8.18.3 Baxter International Amides Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Baxter International Amides Anesthetic Product Portfolio
  108. 8.18.5 Baxter International Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amides Anesthetic Value Chain Analysis
  2. 9.1.1 Amides Anesthetic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amides Anesthetic Production Mode & Process
  6. 9.2 Amides Anesthetic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amides Anesthetic Distributors
  9. 9.2.3 Amides Anesthetic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst